Lysophosphatidic Acid Receptors LPA1 and LPA3 Promote CXCL12-Mediated Smooth Muscle Progenitor Cell Recruitment in Neointima Formation

被引:58
作者
Subramanian, Pallavi [1 ,2 ]
Karshovska, Ela [1 ,3 ]
Reinhard, Patricia [3 ]
Megens, Remco T. A. [1 ,2 ]
Zhou, Zhe [1 ]
Akhtar, Shamima [1 ]
Schumann, Uwe [1 ]
Li, Xiaofeng [1 ,2 ]
van Zandvoort, Marc [1 ,5 ]
Ludin, Christian [4 ]
Weber, Christian [1 ,5 ]
Schober, Andreas [1 ]
机构
[1] Rhein Westfal TH Aachen, Inst Mol Cardiovasc Res, D-52074 Aachen, Germany
[2] Rhein Westfal TH Aachen, Interdisciplinary Ctr Clin Res BIOMAT, Fac Med, D-52074 Aachen, Germany
[3] Univ Munich, Cardiol Unit, Med Policlin, City Ctr Campus, D-80539 Munich, Germany
[4] Polyphor Ltd, Allschwil, Switzerland
[5] Maastricht Univ, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands
关键词
vascular remodeling; vascular smooth muscle; neointima; restenosis; chemokines; SUBTYPE-SELECTIVE ANTAGONISTS; ENDOTHELIAL-CELLS; VASCULAR INJURY; CRUCIAL ROLE; EDG-FAMILY; STEM-CELLS; ACTIVATION; EXPRESSION; ARTERIAL; AXIS;
D O I
10.1161/CIRCRESAHA.109.212647
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rationale: The chemokine CXCL12 (CXC motif ligand 12) and its receptor CXCR 4 (CXC motif receptor 4) direct the recruitment of smooth muscle progenitor cells (SPCs) in neointima formation after vascular injury. Lysophosphatidic acid (LPA) induces CXCL12 and neointimal accumulation of smooth muscle cells (SMCs) in uninjured arteries. Thus, we hypothesize that LPA may regulate CXCL12-mediated vascular remodelling. Objectives: We evaluated the role of LPA receptors in initiating CXCL12-dependent vascular repair by SPCs. Methods and Results: Wire-induced carotid injury was performed in apolipoprotein E-/- mice on western-type diet. LPA receptor expression was studied by immunostaining and quantitative RT-PCR. LPA receptors LPA(1) and LPA(3) were detected in the media of uninjured arteries and in the injury-induced neointima. LPA(3) mRNA was upregulated and LPA(1) mRNA downregulated at one week after injury. The LPA(1/3) antagonist Ki16425 inhibited neointima formation by 71% and reduced both relative neointimal SMCs and the macrophage content. Additionally, neointimal hypoxia-inducible factor-1 alpha and CXCL12 expression, the injury-induced peripheral stem cell antigen-1 (Sca-1)(+)/Lin(-) SPC mobilization, and the neointimal recruitment of Sca-1(+)SMCs were inhibited by Ki16425. In wild type mice, LPA20:4 increased CXCL12 and hypoxia-inducible factor-1 alpha expression in carotid arteries as early as 1 day following short-term endoluminal incubation. LPA20: 4-induced SPC mobilization and neointima formation were blocked by Ki16425, LPA(1)- and LPA(3)-specific small interfering (si) RNA, and the CXCR4 antagonist POL5551. Ki16425 reduced LPA20: 4-mediated neointimal recruitment of SPC as demonstrated by 2-photon microscopy in bone marrow chimeric mice after repopulation with SM22-LacZ transgenic, hematopoietic cells. Moreover, POL5551 decreased the neointimal accumulation of CXCR4(+) SMCs. Conclusions: LPA(1) and LPA(3) promote neointima formation through activation of CXCL12-mediated mobilization and recruitment of SPCs. (Circ Res. 2010; 107: 96-105.)
引用
收藏
页码:96 / U197
页数:21
相关论文
共 46 条
  • [1] Serum lysophosphatidic acid is produced through diverse phospholipase pathways
    Aoki, J
    Taira, A
    Takanezawa, Y
    Kishi, Y
    Hama, K
    Kishimoto, T
    Mizuno, K
    Saku, K
    Taguchi, R
    Arai, H
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (50) : 48737 - 48744
  • [2] Two pathways for lysophosphatidic acid production
    Aoki, Junken
    Inoue, Asuka
    Okudaira, Shinichi
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2008, 1781 (09): : 513 - 518
  • [3] Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA species - Structure-activity relationship of cloned LPA receptors
    Bandoh, K
    Aoki, J
    Taira, A
    Tsujimoto, M
    Arai, H
    Inoue, K
    [J]. FEBS LETTERS, 2000, 478 (1-2) : 159 - 165
  • [4] The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases
    Boucharaba, Ahmed
    Serre, Claire-Marie
    Guglielmi, Julien
    Bordet, Jean-Claude
    Clezardin, Philippe
    Peyruchaud, Olivier
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (25) : 9643 - 9648
  • [5] Lysophosphatidic acid-induced arterial wall remodeling: Requirement of PPARγ but not LPA1 or LPA2 GPCR
    Cheng, Yunhui
    Makarova, Natalia
    Tsukahara, Ryoko
    Guo, Huazhang
    Shuyu, E.
    Farrar, Patricia
    Balazs, Louisa
    Zhang, Chunxiang
    Tigyi, Gabor
    [J]. CELLULAR SIGNALLING, 2009, 21 (12) : 1874 - 1884
  • [6] Biological roles of lysophospholipid receptors revealed by genetic null mice: An update
    Choi, Ji Woong
    Lee, Chang-Wook
    Chun, Jerold
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2008, 1781 (09): : 531 - 539
  • [7] Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation
    Eisenstein, Eric L.
    Anstrom, Kevin J.
    Kong, David F.
    Shaw, Linda K.
    Tuttle, Robert H.
    Mark, Daniel B.
    Kramer, Judith M.
    Harrington, Robert A.
    Matchar, David B.
    Kandzari, David E.
    Peterson, Eric D.
    Schulman, Kevin A.
    Califf, Robert M.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (02): : 159 - 168
  • [8] Morphological predictors of restenosis after coronary stenting in humans
    Farb, A
    Weber, DK
    Kolodgie, FD
    Burke, AP
    Virmani, R
    [J]. CIRCULATION, 2002, 105 (25) : 2974 - 2980
  • [9] Pathological correlates of late drug-eluting stent thrombosis - Strut coverage as a marker of endothelialization
    Finn, Aloke V.
    Joner, Michael
    Nakazawa, Gaku
    Kolodgie, Frank
    Newell, John
    John, Mike C.
    Gold, Herman K.
    Virmani, Renu
    [J]. CIRCULATION, 2007, 115 (18) : 2435 - 2441
  • [10] Fischer DJ, 2001, MOL PHARMACOL, V60, P776